3 unknown, 2 completed. 2 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Unknown 2 |
Follow tecarfarin: new trials by email Literature Review of tecarfarin trials Research Report on tecarfarin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers Tecarfarin - Healthy Chinese Volunteers | Phase 1 | Unknown | Lee's Pharmaceutical Limited | 40 | 2020-04-19 | 2020-11-13 |
| A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers Tecarfarin 10mg, Tecarfarin 20mg, Tecarfarin 30mg - Pharmacokinetic and Pharmacodynamic Profile of Tecarfarin | Phase 1 | Completed | Lee's Pharmaceutical Limited | 40 | 2018-06-22 | 2019-11-21 |
| Tecarfarin Anti-Coagulation Trial (TACT) Warfarin, tecarfarin - Thromboembolism, Thrombosis | Phase 3 | Unknown | Espero Biopharma | 1000 | 2018-06-01 | 2018-01-25 |
| Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter | Phase 2 / Phase 3 | Unknown | ARYx Therapeutics | 600 | 2008-05-01 | 2010-02-02 |
| Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation ATI-5923 - Atrial Fibrillation | Phase 2 | Completed | ARYx Therapeutics | 60 | 2006-12-01 | 2007-11-08 |
Atrial Fibrillation (2) · Atrial Flutter (1) · Cardiomyopathies (1) · Myocardial Infarction (1) · Renal Insufficiency, Chronic (1) · Thromboembolism (1) · Thrombosis (1)
ARYx Therapeutics (2) · Lee's Pharmaceutical Limited (2) · Espero Biopharma (1)
United States (2) · China (1) · Hong Kong (1)
Dave Ellis, M.D., Ph.D (1) · Jo Jo SH Hai, MBBS (1)